Chapter 31. Treatment of Anemia in Chronic Kidney Disease, Stages 3–5

  1. Donald A. Molony MD2,3 and
  2. Jonathan C. Craig MD, PhD4,5
  1. Robert N. Foley MB, MSc

Published Online: 4 MAR 2009

DOI: 10.1002/9781444303391.ch31

Evidence-Based Nephrology

Evidence-Based Nephrology

How to Cite

Foley, R. N. (2008) Treatment of Anemia in Chronic Kidney Disease, Stages 3–5, in Evidence-Based Nephrology (eds D. A. Molony and J. C. Craig), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444303391.ch31

Editor Information

  1. 2

    Division of Renal Disease and Hypertension, University of Texas, USA

  2. 3

    Houston Medical School, Houston, Texas, USA

  3. 4

    School of Public Health, University of Sydney, Australia

  4. 5

    Department of Nephrology, The Children's Hospital at Westmead, Sydney, Australia

Author Information

  1. Chronic Disease Research Group, University of Minnesota, Minneapolis, Minnesota, USA

Publication History

  1. Published Online: 4 MAR 2009
  2. Published Print: 5 DEC 2008

ISBN Information

Print ISBN: 9781405139755

Online ISBN: 9781444303391



  • chronic kidney disease (CKD;
  • hemoglobin targets in CKD;
  • mortality and major cardiovascular events;
  • quality of life;
  • treatment of anemia in CKD;
  • hemodialysis access;
  • iron intervention trials;
  • modes of administration of iron


This chapter contains sections titled:

  • Introduction

  • Evaluation of anemia in CKD

  • Hemoglobin targets in CKD

  • Use of ESAs

  • Iron therapy

  • References